3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
38
Stomach Neoplasms
24
Rectal Neoplasms
19
Pancreatic Neoplasms
17
Lymphoma, Large B-Cell, Diffuse
14
Colonic Neoplasms
14
Esophageal Neoplasms
12
Adenocarcinoma Of Esophagus
12
Carcinoma, Non-Small-Cell Lung
10
Neoplasms
9
Neoplasm Metastasis
9
Adenocarcinoma
9
Cholangiocarcinoma
8
Biliary Tract Neoplasms
6
Ovarian Neoplasms
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Esophageal Squamous Cell Carcinoma
4
Carcinoma, Hepatocellular
4
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Lung Neoplasms
3
Gallbladder Neoplasms
3
Endometrial Neoplasms
3
Carcinoma
3
Bile Duct Neoplasms
3
Advanced Solid Tumors
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Spinocerebellar Degenerations
2
Recurrence
2
Interventions
Cyclophosphamide
5
Etoposide
3
duvelisib
2
Vincristine
2
Prednisone
2
Melphalan
2
Doxorubicin
2
Azacitidine
2
10-propargyl-10-deazaaminopterin
2
tazemetostat
1
sodium-iodide symporter
1
ruxolitinib
1
pembrolizumab
1
fludarabine phosphate
1
fludarabine
1
etoposide phosphate
1
cemiplimab
1
belinostat
1
X-Rays
1
Whole-Body Irradiation
1
Tacrolimus
1
Specimen Handling
1
Sirolimus
1
Prednisolone
1
Photons
1
Peripheral Blood Stem Cell Transplantation
1
Nivolumab
1
Mycophenolic Acid
1
Methotrexate
1
Magnetic Resonance Spectroscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoblastic Lymphadenopathy
×
Oxaliplatin
×
90 days
×
Clear all
No trials found.